Immix Biopharma Inc (IMMX) Stock Analysis
Verdict: WATCH (do not buy)
A strong $93.93M cash runway and $26 analyst targets propel IMMX, but zero revenue and clinical binary risk cap short-term probability.
Investment score: 54/100
Analysis as of
Is Immix Biopharma Inc stock worth reviewing? The TradeMates thesis
The model views IMMX as a high-potential speculative clinical biotech backed by $93.93M in cash (~45 months runway) and strategic clinical ties with BeiGene, balanced by zero product revenue and trailing EPS misses.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 65/100 (weight 15%)
- Technical Momentum: 75/100 (weight 15%)
- Earnings Quality: 35/100 (weight 15%)
- Insider Sentiment: 50/100 (weight 10%)
- Analyst Consensus: 85/100 (weight 10%)
- Risk-Adjusted Return: 55/100 (weight 15%)
Immix Biopharma Inc opportunities and risks
What speaks for IMMX
- Robust $93.93M Cash Cushion (~45 Months Runway)
What speaks against IMMX
- Binary Clinical Trial Failure Risk Across Core Pipeline
Peers and competitors
- SLDB
- FTH
- SANA
- AVTX
- OLMA
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| IMMX | n/a | 0.0x | n/a | 0.0% | 0.0% | -5.7% |
| SLDB | n/a | 0.0x | n/a | 0.0% | 0.0% | -21.6% |
| FTH | n/a | n/a | n/a | 2740.8% | 4030.7% | -3.7% |
| SANA | n/a | 0.0x | n/a | 0.0% | 0.0% | -15.0% |
| AVTX | n/a | 15001.4x | n/a | -16861.0% | -170055.9% | -7.5% |
| OLMA | n/a | 0.0x | n/a | 0.0% | 0.0% | -18.5% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -15.0% |
Frequently asked questions about Immix Biopharma Inc (IMMX)
Is IMMX stock a good investment?
The TradeMates model rates Immix Biopharma Inc as WATCH (do not buy) with an investment score of 54/100. The model views IMMX as a high-potential speculative clinical biotech backed by $93.93M in cash (~45 months runway) and strategic clinical ties with BeiGene, balanced by zero product revenue and trailing EPS misses. This is algorithmic model output, not personal investment advice.
Is IMMX stock a buy?
The TradeMates model verdict for IMMX is WATCH (do not buy) with an investment score of 54/100. Treat this as a model signal to review, not a personal buy recommendation.